Why has the Fisher & Paykel share price tumbled?

Amid a cooling in sales growth, the Fisher & Paykel share price has tumbled throughout the front end of this year. Since the turn of 2022, shares in the respiratory device manufacturer have diminished by 39% in value. For comparison, the S&P/ASX 200 Index (ASX: XJO) has fallen nearly 6% — which is still 33% better than the healthcare company.

Is Fisher & Paykel a publicly traded company?

Fisher & Paykel healthcare corporation is a publicly-traded company founded in 1934 and has its headquarters in New Zealand. Also, the company is operating in more than 120 countries worldwide. It designs, manufactures, and markets the products and systems that are used in respiratory care, acute care, and the treatment of obstructive sleep apnea.

Is Fisher & Paykel a luxury brand?

On the other side of the world, luxury goes by the name of Fisher & Paykel, but to this side of the globe, the brand remains relatively unknown to the common appliance shopper.